• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, Back to Search Results
Catalog Number EUP22510X
Device Problem Use of Device Problem (1670)
Patient Problems Nausea (1970); Vascular Dissection (3160)
Event Date 03/04/2022
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the euphora, solarice, nc euphora, nc solarice and sprinter legend poba balloon catheters, everest inflation device & accessories.Survey results are from a cardiovascular surgeon in practice 13 years.In the past two months, the physician has used euphora rx, sprinter legend and everest devices.The physician uses approximately 4 euphora rx, 2 sprinter legend and 5 everest devices in an average month.During one procedure one euphora rx balloon catheter was used to treat a patient with acute coronary syndrome.The device was being used for angioplasty alone.It was reported that a balloon leak and a detachment occurred in vitro, prior to insertion, when the device was being flushed/prepped.It was also reported that during the procedure a grade a coronary vessel dissection occurred and the patient developed nausea.The dissection was described as being directly related to the euphora rx device, as too high of a pressure was used during dilation.The nausea was reported as being related to the procedure but not directly to the device itself.It was indicated that the device performed successfully in its ability to dilate the stenotic portion of a lesion in the native coronary artery to improve myocardial infusion.No further patient injury reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUPHORA RX
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14489055
MDR Text Key292522462
Report Number9612164-2022-01987
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K143480
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEUP22510X
Was Device Available for Evaluation? No
Date Manufacturer Received04/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-